Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2006 1
2010 1
2011 1
2018 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Immunology and Pathology in Ocular Drug Development.
Ramos MF, Brassard J, Masli S. Ramos MF, et al. Among authors: brassard j. Toxicol Pathol. 2021 Apr;49(3):483-504. doi: 10.1177/0192623320978396. Epub 2021 Jan 20. Toxicol Pathol. 2021. PMID: 33468035 Review.
Nonproliferative and Proliferative Lesions of the Ratand Mouse Special Sense Organs(Ocular [eye and glands], Olfactory and Otic).
Ramos MF, Baker J, Atzpodien EA, Bach U, Brassard J, Cartwright J, Farman C, Fishman C, Jacobsen M, Junker-Walker U, Kuper F, Moreno MCR, Rittinghausen S, Schafer K, Tanaka K, Teixeira L, Yoshizawa K, Zhang H. Ramos MF, et al. Among authors: brassard j. J Toxicol Pathol. 2018;31(3 Suppl):97S-214S. doi: 10.1293/tox.31.97S. Epub 2018 Jul 28. J Toxicol Pathol. 2018. PMID: 30158741 Free PMC article. Review. No abstract available.
Review of continuing education course on hemostasis.
Baker DC, Brassard J. Baker DC, et al. Among authors: brassard j. Toxicol Pathol. 2011 Jan;39(1):281-8. doi: 10.1177/0192623310389476. Epub 2010 Dec 3. Toxicol Pathol. 2011. PMID: 21131603 Review.
Drug-induced thrombocytopenia and thrombosis: evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial.
Scirica BM, Cannon CP, Cooper R, Aster RH, Brassard J, McCabe CH, Charlesworth A, Skene AM, Braunwald E. Scirica BM, et al. Among authors: brassard j. J Thromb Thrombolysis. 2006 Oct;22(2):95-102. doi: 10.1007/s11239-006-8669-4. J Thromb Thrombolysis. 2006. PMID: 17008974 Clinical Trial.